Smith & Nephew plc

1,161pAs of Sun 8 Nov 2026, 12:00 UTC
LSE:SNHealthcare
Ctry United Kingdom
PE (Fwd) •••
TSR 10Y CAGR 2.34%
Div yield 2.52%
ROE 11.85%
Medical Devices
Beta (5Y) 0.67
PE TTM 20.86
TSR TTM (13.55%)
Mkt cap £9.718B
ROIC 8.69%
SE Grade™
Value
Quality
Moat
Consensus
Reference
1,117p
(3.79%)
(54.05%)
Hold 4|4|3|12|10
4Q25
1Q26
2Q26
3Q26
Earnings per share$
22.12
21.06
21.53
21.75
22.15%
4.31%
(2.20%)
(1.39%)
Revenue$M
499.4
525.7
551.7
570.3
7.68%
10.76%
14.13%
14.45%
Peers (US$13.08B)
Cap (US$)
PE
6.585B
53.61x
4.957B
25.73x
825.5M
171.0x
Capital
TTM
5Y
10Y
Leveragex
5.030
0.141
0.122
EBIT/Intx
3.480
0.607
0.533
Own earn%
(43.70)
181.10
189.81
Sh yield%
8.09
25.73
25.72
Owners
Insiders/Inst%
8.82
56.22
Short interest%
5.71
SBC / revenue%
5.43
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
21
Op margin range%
22–29
$1 testx
0.0
Incr. ROIC%
28